Home

Team

Investment Approach

For Entrepreneurs

Portfolio Companies

News & Events

Archive

News & Events

Page

2 3

Celladon Corporation Announces First European Patient Dosed in Phase 2b Trial

12 / 12 / 2012

Hatchtech completes financing round, commencing Phase 3 for Headlice Treatment

12 / 12 / 2012

Video: Channel 7 Sunrise on the HypoMon

10 / 12 / 2012

RBS Morgans: All systems go on Sunshine Heart

04 / 12 / 2012

Beating Breast Cancer

29 / 11 / 2012

Sydney 2012 Design Awards HypoMon® Hypoglycaemia Monitor

23 / 11 / 2012

Sunshine Heart Receives Unconditional FDA Approval for C-Pulse® System�??s U.S. Pivotal Trial

21 / 11 / 2012

Summer Street - Sunshine Heart Release

12 / 11 / 2012

Canaccord Genuity Report- Sunshine heart

12 / 11 / 2012

AirXpanders Announces European CE Mark Approval for AeroForm

08 / 11 / 2012

AirXpanders Announces Preliminary Results from Two Clinical Studies

08 / 11 / 2012

Lazard Capital Markets Report: Sunshine Hearts

24 / 10 / 2012

Sunshine Heart Receives 2012 Frost & Sullivan Innovation Award

24 / 10 / 2012

NEUROVANCE CLOSES $7M SERIES A1 ROUND FOR DEVELOPMENT OF EB-1020 FOR ADHD

18 / 10 / 2012

AiMedics Alarm that lets you Sleep Easier

15 / 10 / 2012

EUTHYMICS COMPLETES ENROLLMENT IN TRIADE

15 / 10 / 2012

Sunshine Heart Appoints John Erb to Chairman of the Board

27 / 09 / 2012

FierceBiotech's 2012 Fierce 15

24 / 09 / 2012

Celladon Corporation Named a 2012 Fierce 15 Company by FierceBiotech

19 / 09 / 2012

KaloBios Initiates Phase 2 Study with KB003 Humaneered�?� Monoclonal Antibody in Severe Asthma

11 / 09 / 2012

Sunshine Heart Submits Investigational Device Exemption to FDA for C-Pulse® System Pivotal Trial

11 / 09 / 2012

KaloBios Completes Debt Financing of Up to $15 Million

07 / 09 / 2012

Proacta Incorporated Announces IND Approval for PR610

28 / 08 / 2012

Sunshine hearts Craig-Hallum

24 / 08 / 2012

Sunshine Hearts RBS Morgans Report

15 / 08 / 2012

Displaying records 1-25 of 64